The commencement regulations for the Psychoactive Substances Act were laid on 5 May 2016 and the Act will come into force on 26 May 2016.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4110", "label" : {"_value" : "Biography information for Dame Karen Bradley"} } , "answeringMemberConstituency" : {"_value" : "Staffordshire Moorlands"} , "answeringMemberPrinted" : {"_value" : "Karen Bradley"} , "dateOfAnswer" : {"_value" : "2016-05-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-05-10T12:15:45.357Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2016-05-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Psychoactive Substances Act 2016"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, pursuant to the Answer of 13 April 2016 to Question 33406, when the Psychoactive Substances Act 2016 will come into force in its entirety.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"} } , "tablingMemberConstituency" : {"_value" : "Barnsley Central"} , "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"} ], "uin" : "36355"} , {"_about" : "http://data.parliament.uk/resources/516222", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/516222/answer", "answerText" : {"_value" : "
Local authorities have the legal responsibility for deciding what financial support should be provided to families supporting children under a Child Arrangements Order (previously known as a residence order). We do not propose to introduce a national standardised means test for Child Arrangements Order allowances.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1605", "label" : {"_value" : "Biography information for Edward Timpson"} } , "answeringMemberConstituency" : {"_value" : "Crewe and Nantwich"} , "answeringMemberPrinted" : {"_value" : "Edward Timpson"} , "dateOfAnswer" : {"_value" : "2016-05-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-05-09T14:43:54.467Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2016-04-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Residence Orders"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Education, if her Department will make an assessment of the potential merits of (a) introducing a Standardised Means Test for Residence Order Payments and (b) making the use of such a test a statutory requirement for local authorities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"} } , "tablingMemberConstituency" : {"_value" : "Barnsley Central"} , "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"} ], "uin" : "35871"} , {"_about" : "http://data.parliament.uk/resources/515933", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/515933/answer", "answerText" : {"_value" : "
The Epilepsy Society paper presents the findings of the National General Practice Study of Epilepsy (NGPSE), a 25-year cohort analysis of 558 people having recurring unprovoked seizures, and also considers more widely the issue of premature mortality and death in epilepsy. The NGPSE study found that 189 (34%) of the cohort died during the 25 year follow-up period, and six people in this group (3%) had died directly due to their epilepsy. The NGPSE also found a frequent link between co-morbidity in epilepsy and death.<\/p>
Increasing numbers of people have multiple long term conditions (LTCs), not just single diseases, and that the management of comorbidity and multimorbidity presents a significant challenge to the National Health Service. It is an issue highlighted in the Five Year Forward View and defined as a central task of the NHS. Improving the support and choice provided to people with LTCs and enabling them to live healthy independent lives remains a key ambition for this Government. NHS England is responding with specific actions to improve the delivery of personalised care planning, self-management support and personal health budgets, as well as helping to support the development of new service models that deliver care that is more proactive and less reactive in the management of patients with LTCs. More information can be found in NHS England\u2019s Business Plan for 2016-17, available at the following link:<\/p>
www.england.nhs.uk/wp-content/uploads/2016/03/bus-plan-16.pdf<\/a> Regarding the matter of variation in epilepsy mortality, the Neurology Intelligence Network (NIN), a partnership programme between Public Health England (PHE) and NHS England, has produced a detailed epilepsy profile presenting data at clinical commissioning group (CGG) level against 20 separate indicators, including mortality. CGGs should consider mortality rates alongside other indicators such as prevalence and unplanned admission rates, and in the wider socioeconomic context of their local area to understand the challenges and consider what improvement activity may be appropriate. NHS England is also taking specific action to target unwarranted variation in treatment and outcomes across range of conditions, including epilepsy, through the Rightcare Programme, which is being rolled out to all CCGs in 2016-17. The NIN profiles can be found at the following link: Finally, as previously set out, the Healthcare Quality Improvement Partnership commissions, develops and manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England, Wales and other devolved administration. There are no specific plans for an audit to cover all cases of avoidable deaths from epilepsy at this time.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-05-04", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "35729"}
, {"_value" : "35730"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-05-04T09:25:41.32Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-04-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy: Death"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 19 April 2016 to Question 33552, if the National Clinical Audit and Patient Outcomes Programme will audit the number of avoidable deaths from epilepsy in adults.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "35728"}
, {"_about" : "http://data.parliament.uk/resources/515939", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/515939/answer", "answerText" : {"_value" : " The Epilepsy Society paper presents the findings of the National General Practice Study of Epilepsy (NGPSE), a 25-year cohort analysis of 558 people having recurring unprovoked seizures, and also considers more widely the issue of premature mortality and death in epilepsy. The NGPSE study found that 189 (34%) of the cohort died during the 25 year follow-up period, and six people in this group (3%) had died directly due to their epilepsy. The NGPSE also found a frequent link between co-morbidity in epilepsy and death.<\/p> Increasing numbers of people have multiple long term conditions (LTCs), not just single diseases, and that the management of comorbidity and multimorbidity presents a significant challenge to the National Health Service. It is an issue highlighted in the Five Year Forward View and defined as a central task of the NHS. Improving the support and choice provided to people with LTCs and enabling them to live healthy independent lives remains a key ambition for this Government. NHS England is responding with specific actions to improve the delivery of personalised care planning, self-management support and personal health budgets, as well as helping to support the development of new service models that deliver care that is more proactive and less reactive in the management of patients with LTCs. More information can be found in NHS England\u2019s Business Plan for 2016-17, available at the following link:<\/p> www.england.nhs.uk/wp-content/uploads/2016/03/bus-plan-16.pdf<\/a> Regarding the matter of variation in epilepsy mortality, the Neurology Intelligence Network (NIN), a partnership programme between Public Health England (PHE) and NHS England, has produced a detailed epilepsy profile presenting data at clinical commissioning group (CGG) level against 20 separate indicators, including mortality. CGGs should consider mortality rates alongside other indicators such as prevalence and unplanned admission rates, and in the wider socioeconomic context of their local area to understand the challenges and consider what improvement activity may be appropriate. NHS England is also taking specific action to target unwarranted variation in treatment and outcomes across range of conditions, including epilepsy, through the Rightcare Programme, which is being rolled out to all CCGs in 2016-17. The NIN profiles can be found at the following link: Finally, as previously set out, the Healthcare Quality Improvement Partnership commissions, develops and manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England, Wales and other devolved administration. There are no specific plans for an audit to cover all cases of avoidable deaths from epilepsy at this time.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-05-04", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "35728"}
, {"_value" : "35729"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-05-04T09:25:41.257Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-04-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy: Death"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 19 April 2016 to Question 33552, what assessment he has made of the implications for his Department's policy of the Epilepsy Society's longitudinal study on epilepsy mortality.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "35730"}
, {"_about" : "http://data.parliament.uk/resources/515945", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/515945/answer", "answerText" : {"_value" : " The Epilepsy Society paper presents the findings of the National General Practice Study of Epilepsy (NGPSE), a 25-year cohort analysis of 558 people having recurring unprovoked seizures, and also considers more widely the issue of premature mortality and death in epilepsy. The NGPSE study found that 189 (34%) of the cohort died during the 25 year follow-up period, and six people in this group (3%) had died directly due to their epilepsy. The NGPSE also found a frequent link between co-morbidity in epilepsy and death.<\/p> Increasing numbers of people have multiple long term conditions (LTCs), not just single diseases, and that the management of comorbidity and multimorbidity presents a significant challenge to the National Health Service. It is an issue highlighted in the Five Year Forward View and defined as a central task of the NHS. Improving the support and choice provided to people with LTCs and enabling them to live healthy independent lives remains a key ambition for this Government. NHS England is responding with specific actions to improve the delivery of personalised care planning, self-management support and personal health budgets, as well as helping to support the development of new service models that deliver care that is more proactive and less reactive in the management of patients with LTCs. More information can be found in NHS England\u2019s Business Plan for 2016-17, available at the following link:<\/p> www.england.nhs.uk/wp-content/uploads/2016/03/bus-plan-16.pdf<\/a> Regarding the matter of variation in epilepsy mortality, the Neurology Intelligence Network (NIN), a partnership programme between Public Health England (PHE) and NHS England, has produced a detailed epilepsy profile presenting data at clinical commissioning group (CGG) level against 20 separate indicators, including mortality. CGGs should consider mortality rates alongside other indicators such as prevalence and unplanned admission rates, and in the wider socioeconomic context of their local area to understand the challenges and consider what improvement activity may be appropriate. NHS England is also taking specific action to target unwarranted variation in treatment and outcomes across range of conditions, including epilepsy, through the Rightcare Programme, which is being rolled out to all CCGs in 2016-17. The NIN profiles can be found at the following link: Finally, as previously set out, the Healthcare Quality Improvement Partnership commissions, develops and manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England, Wales and other devolved administration. There are no specific plans for an audit to cover all cases of avoidable deaths from epilepsy at this time.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-05-04", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "35728"}
, {"_value" : "35730"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-05-04T09:25:41.367Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-04-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy: Death"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 19 April 2016 to Question 33552, if he will make an assessment of the extent of regional variation in premature death from epilepsy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "35729"}
, {"_about" : "http://data.parliament.uk/resources/514754", "AnsweringBody" : [{"_value" : "Department for Education"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/514754/answer", "answerText" : {"_value" : " Our White Paper, Education Excellence Everywhere, sets out the range of support we will offer to schools across England.<\/p> <\/p> Where schools are failing, Regional Schools Commissioners will identify a suitable academy sponsor to turn them around. In areas where there are too few sponsors, we will recruit new sponsors, including high-performing schools and more sponsors from business, charity and philanthropy. We will also encourage existing sponsors to expand, increasing incentives and minimising barriers, learning from the investment we have already made through the Northern Sponsor Fund.<\/p> <\/p> For other struggling schools, we will ensure there is nationwide coverage of system leaders (teaching schools and National Leaders of Education), who will be expected to work with weaker schools to support them to improve. To help achieve this, we will improve how we designate system leaders by introducing a more sophisticated approach based on timely and accurate data rather than relying heavily on Ofsted judgements. We will also partner schools with the potential to become strong system leaders with existing teaching schools and National Leaders of Education.<\/p> <\/p> Through the Department\u2019s strategy for Achieving Excellence Areas, we will target our existing programmes to secure sufficient high quality teachers, leaders, system leaders, sponsors and members of governing boards on the areas of greatest need. At the Budget, the Government announced that we will invest an additional £20 million a year to build on this strategy to raise education standards across the Northern Powerhouse. The allocation of this funding will depend on the identified need and will be reassessed each year, based on the evidence.<\/p> For the additional funding announced in the budget, decisions on how the funding will be allocated for the 2016-17 financial year will be made by the autumn of this year and will be informed by the emerging findings of the review by Sir Nick Weller. We will be publishing the terms of reference for Sir Nick Weller\u2019s review shortly.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/111", "label" : {"_value" : "Biography information for Nick Gibb"}
}
, "answeringMemberConstituency" : {"_value" : "Bognor Regis and Littlehampton"}
, "answeringMemberPrinted" : {"_value" : "Nick Gibb"}
, "dateOfAnswer" : {"_value" : "2016-05-05", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "34992"}
, {"_value" : "35015"}
, {"_value" : "35025"}
, {"_value" : "35045"}
, {"_value" : "35105"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-05-05T13:05:02.267Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2016-04-21", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Education: North of England"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, when her Department plans to publish the terms of reference for Sir Nick Weller's report into transforming education across the Northern Powerhouse.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "35014"}
, {"_about" : "http://data.parliament.uk/resources/514755", "AnsweringBody" : [{"_value" : "Department for Education"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/514755/answer", "answerText" : {"_value" : " Our White Paper, Education Excellence Everywhere, sets out the range of support we will offer to schools across England.<\/p> <\/p> Where schools are failing, Regional Schools Commissioners will identify a suitable academy sponsor to turn them around. In areas where there are too few sponsors, we will recruit new sponsors, including high-performing schools and more sponsors from business, charity and philanthropy. We will also encourage existing sponsors to expand, increasing incentives and minimising barriers, learning from the investment we have already made through the Northern Sponsor Fund.<\/p> <\/p> For other struggling schools, we will ensure there is nationwide coverage of system leaders (teaching schools and National Leaders of Education), who will be expected to work with weaker schools to support them to improve. To help achieve this, we will improve how we designate system leaders by introducing a more sophisticated approach based on timely and accurate data rather than relying heavily on Ofsted judgements. We will also partner schools with the potential to become strong system leaders with existing teaching schools and National Leaders of Education.<\/p> <\/p> Through the Department\u2019s strategy for Achieving Excellence Areas, we will target our existing programmes to secure sufficient high quality teachers, leaders, system leaders, sponsors and members of governing boards on the areas of greatest need. At the Budget, the Government announced that we will invest an additional £20 million a year to build on this strategy to raise education standards across the Northern Powerhouse. The allocation of this funding will depend on the identified need and will be reassessed each year, based on the evidence.<\/p> For the additional funding announced in the budget, decisions on how the funding will be allocated for the 2016-17 financial year will be made by the autumn of this year and will be informed by the emerging findings of the review by Sir Nick Weller. We will be publishing the terms of reference for Sir Nick Weller\u2019s review shortly.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/111", "label" : {"_value" : "Biography information for Nick Gibb"}
}
, "answeringMemberConstituency" : {"_value" : "Bognor Regis and Littlehampton"}
, "answeringMemberPrinted" : {"_value" : "Nick Gibb"}
, "dateOfAnswer" : {"_value" : "2016-05-05", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "34992"}
, {"_value" : "35014"}
, {"_value" : "35025"}
, {"_value" : "35045"}
, {"_value" : "35105"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-05-05T13:05:02.33Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2016-04-21", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Schools: North of England"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, how the Northern Powerhouse schools strategy plans to fast-track the best (a) schools to become teaching schools and (b) local heads to become national leaders of education.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "35015"}
, {"_about" : "http://data.parliament.uk/resources/511392", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/511392/answer", "answerText" : {"_value" : " The National Health Service has made no such assessment.<\/p> The NHS has to comply with the Control of Substances Hazardous to Health Regulations 2002 (COSHH). This applies in the workplace when hazardous substances are manufactured, used or where processes are undertaken that generate hazardous substances. COSHH requires the employer to carry out a risk assessment to establish what, if any, hazards are associated with products/processes employees are using/undertaking and then put measures in place to control exposure to those hazards.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2016-04-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-04-19T14:08:04.787Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Formaldehyde"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 14 March 2016 to Question 31000, what assessment the NHS has made of the potential causal link between formaldehyde contained in everyday products and eczema and other atopic conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4243", "label" : {"_value" : "Biography information for Dan Jarvis"}
}
, "tablingMemberConstituency" : {"_value" : "Barnsley Central"}
, "tablingMemberPrinted" : [{"_value" : "Dan Jarvis"}
], "uin" : "33502"}
, {"_about" : "http://data.parliament.uk/resources/511403", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/511403/answer", "answerText" : {"_value" : " The Healthcare Quality Improvement Partnership commissions, develops and manages the National Clinical Audit and Patient Outcomes Programme (NCAPOP), on behalf of NHS England, Wales and other devolved administrations. Whilst there is no specific audit planned that covers all cases of avoidable deaths from epilepsy, the following NCAPOP audits and reviews are of relevance:<\/p> - The audit for paediatric epilepsy, which is being re-commissioned this year, covers the quality of health care services for children and young people with epilepsy in the United Kingdom. The audit is managed by the Royal College of Paediatrics and Child Health (RCPCH) and the first audit report can be found at the following link:<\/p> www.rcpch.ac.uk/news/variation-care-children-epilepsy-revealed-first-uk-wide-audit<\/a><\/p> - The 2013 review report into cases of mortality and prolonged seizures in children and young people with epilepsies that was managed by the RCPCH. The report is available at the following link:<\/p> www.rcpch.ac.uk/child-health-reviews-uk/programme-findings/programme-findings-chr-uk<\/a><\/p> - The recently commissioned national mortality case record review programme for England and Scotland which aims to improve understanding and learning about problems in care that may have contributed to a patient\u2019s death:<\/p> www.rcplondon.ac.uk/news/rcp-hosts-pioneering-national-mortality-case-record-review-programme<\/a><\/p> - The maternal, newborn and infant clinical outcome review programme will be undertaking a review of cases of mortality and morbidity for pregnant women with severe epilepsy that will report in December 2017. This will be carried out by MBRRACE-UK at the University of Oxford. Further information can be found at the following link:<\/p>
Guidance from the National Institute for Health and Care Excellence (NICE) on the diagnosis and management of epilepsy covers the issue of comorbidity, including polypharmacy. However, in recognition of this increasing problem, NICE is also working to produce a new clinical guideline on the management of multimorbidity in a range of common conditions which is scheduled for publication in September 2016.<\/p>
http://fingertips.phe.org.uk/profile-group/mental-health/profile/neurology<\/a><\/p>
Guidance from the National Institute for Health and Care Excellence (NICE) on the diagnosis and management of epilepsy covers the issue of comorbidity, including polypharmacy. However, in recognition of this increasing problem, NICE is also working to produce a new clinical guideline on the management of multimorbidity in a range of common conditions which is scheduled for publication in September 2016.<\/p>
http://fingertips.phe.org.uk/profile-group/mental-health/profile/neurology<\/a><\/p>
Guidance from the National Institute for Health and Care Excellence (NICE) on the diagnosis and management of epilepsy covers the issue of comorbidity, including polypharmacy. However, in recognition of this increasing problem, NICE is also working to produce a new clinical guideline on the management of multimorbidity in a range of common conditions which is scheduled for publication in September 2016.<\/p>
http://fingertips.phe.org.uk/profile-group/mental-health/profile/neurology<\/a><\/p>